The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Plasma-derived Medicinal Products-Global Market Insights and Sales Trends 2025
Synopsis
Plasma-derived medicinal products (PDMPs) are industrially manufactured from human plasma by pharmaceutical companies. Plasma is the liquid part of blood and it can be collected through specific procedures called plasmapheresis or obtained by the separation from the other components through physical means (centrifugation). PDMPs play a key, and sometimes non-replaceable, role in the treatment of many acute and chronic clinical conditions.
The global Plasma-derived Medicinal Products market size is expected to reach US$ 47160 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Plasma-derived Medicinal Products in various end use industries. The expanding demands from the Emergency Care, Epidemic Diseasae, Immune System Disorder and Antibody Deficiency, are propelling Plasma-derived Medicinal Products market. Immunoglobulins, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Coagulation Factor Concentrates segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plasma-derived Medicinal Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plasma-derived Medicinal Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plasma-derived Medicinal Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plasma-derived Medicinal Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plasma-derived Medicinal Products covered in this report include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and Shanghai RAAS, etc.
The global Plasma-derived Medicinal Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
Global Plasma-derived Medicinal Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasma-derived Medicinal Products market, Segment by Type:
Immunoglobulins
Coagulation Factor Concentrates
Other
Global Plasma-derived Medicinal Products market, by Application
Emergency Care
Epidemic Diseasae
Immune System Disorder
Antibody Deficiency
Coagulation Disorder
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Plasma-derived Medicinal Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Plasma-derived Medicinal Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Plasma-derived medicinal products (PDMPs) are industrially manufactured from human plasma by pharmaceutical companies. Plasma is the liquid part of blood and it can be collected through specific procedures called plasmapheresis or obtained by the separation from the other components through physical means (centrifugation). PDMPs play a key, and sometimes non-replaceable, role in the treatment of many acute and chronic clinical conditions.
The global Plasma-derived Medicinal Products market size is expected to reach US$ 47160 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Plasma-derived Medicinal Products in various end use industries. The expanding demands from the Emergency Care, Epidemic Diseasae, Immune System Disorder and Antibody Deficiency, are propelling Plasma-derived Medicinal Products market. Immunoglobulins, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Coagulation Factor Concentrates segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plasma-derived Medicinal Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plasma-derived Medicinal Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plasma-derived Medicinal Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plasma-derived Medicinal Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plasma-derived Medicinal Products covered in this report include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and Shanghai RAAS, etc.
The global Plasma-derived Medicinal Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
Global Plasma-derived Medicinal Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasma-derived Medicinal Products market, Segment by Type:
Immunoglobulins
Coagulation Factor Concentrates
Other
Global Plasma-derived Medicinal Products market, by Application
Emergency Care
Epidemic Diseasae
Immune System Disorder
Antibody Deficiency
Coagulation Disorder
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Plasma-derived Medicinal Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Plasma-derived Medicinal Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Plasma-derived Medicinal Products Market Overview
1.1 Plasma-derived Medicinal Products Product Overview
1.2 Plasma-derived Medicinal Products Market Segment by Type
1.2.1 Immunoglobulins
1.2.2 Coagulation Factor Concentrates
1.2.3 Other
1.3 Global Plasma-derived Medicinal Products Market Size by Type
1.3.1 Global Plasma-derived Medicinal Products Market Size Overview by Type (2018-2029)
1.3.2 Global Plasma-derived Medicinal Products Historic Market Size Review by Type (2018-2023)
1.3.3 Global Plasma-derived Medicinal Products Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Plasma-derived Medicinal Products Sales Breakdown by Type (2018-2023)
1.4.2 Europe Plasma-derived Medicinal Products Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Plasma-derived Medicinal Products Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Plasma-derived Medicinal Products Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Plasma-derived Medicinal Products Sales Breakdown by Type (2018-2023)
2 Global Plasma-derived Medicinal Products Market Competition by Company
2.1 Global Top Players by Plasma-derived Medicinal Products Sales (2018-2023)
2.2 Global Top Players by Plasma-derived Medicinal Products Revenue (2018-2023)
2.3 Global Top Players by Plasma-derived Medicinal Products Price (2018-2023)
2.4 Global Top Manufacturers Plasma-derived Medicinal Products Manufacturing Base Distribution, Sales Area, Product Type
2.5 Plasma-derived Medicinal Products Market Competitive Situation and Trends
2.5.1 Plasma-derived Medicinal Products Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Plasma-derived Medicinal Products Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma-derived Medicinal Products as of 2022)
2.7 Date of Key Manufacturers Enter into Plasma-derived Medicinal Products Market
2.8 Key Manufacturers Plasma-derived Medicinal Products Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Plasma-derived Medicinal Products Status and Outlook by Region
3.1 Global Plasma-derived Medicinal Products Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Plasma-derived Medicinal Products Historic Market Size by Region
3.2.1 Global Plasma-derived Medicinal Products Sales in Volume by Region (2018-2023)
3.2.2 Global Plasma-derived Medicinal Products Sales in Value by Region (2018-2023)
3.2.3 Global Plasma-derived Medicinal Products Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Plasma-derived Medicinal Products Forecasted Market Size by Region
3.3.1 Global Plasma-derived Medicinal Products Sales in Volume by Region (2024-2029)
3.3.2 Global Plasma-derived Medicinal Products Sales in Value by Region (2024-2029)
3.3.3 Global Plasma-derived Medicinal Products Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Plasma-derived Medicinal Products by Application
4.1 Plasma-derived Medicinal Products Market Segment by Application
4.1.1 Emergency Care
4.1.2 Epidemic Diseasae
4.1.3 Immune System Disorder
4.1.4 Antibody Deficiency
4.1.5 Coagulation Disorder
4.1.6 Others
4.2 Global Plasma-derived Medicinal Products Market Size by Application
4.2.1 Global Plasma-derived Medicinal Products Market Size Overview by Application (2018-2029)
4.2.2 Global Plasma-derived Medicinal Products Historic Market Size Review by Application (2018-2023)
4.2.3 Global Plasma-derived Medicinal Products Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Plasma-derived Medicinal Products Sales Breakdown by Application (2018-2023)
4.3.2 Europe Plasma-derived Medicinal Products Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Plasma-derived Medicinal Products Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Plasma-derived Medicinal Products Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Plasma-derived Medicinal Products Sales Breakdown by Application (2018-2023)
5 North America Plasma-derived Medicinal Products by Country
5.1 North America Plasma-derived Medicinal Products Historic Market Size by Country
5.1.1 North America Plasma-derived Medicinal Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Plasma-derived Medicinal Products Sales in Volume by Country (2018-2023)
5.1.3 North America Plasma-derived Medicinal Products Sales in Value by Country (2018-2023)
5.2 North America Plasma-derived Medicinal Products Forecasted Market Size by Country
5.2.1 North America Plasma-derived Medicinal Products Sales in Volume by Country (2024-2029)
5.2.2 North America Plasma-derived Medicinal Products Sales in Value by Country (2024-2029)
6 Europe Plasma-derived Medicinal Products by Country
6.1 Europe Plasma-derived Medicinal Products Historic Market Size by Country
6.1.1 Europe Plasma-derived Medicinal Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Plasma-derived Medicinal Products Sales in Volume by Country (2018-2023)
6.1.3 Europe Plasma-derived Medicinal Products Sales in Value by Country (2018-2023)
6.2 Europe Plasma-derived Medicinal Products Forecasted Market Size by Country
6.2.1 Europe Plasma-derived Medicinal Products Sales in Volume by Country (2024-2029)
6.2.2 Europe Plasma-derived Medicinal Products Sales in Value by Country (2024-2029)
7 Asia-Pacific Plasma-derived Medicinal Products by Region
7.1 Asia-Pacific Plasma-derived Medicinal Products Historic Market Size by Region
7.1.1 Asia-Pacific Plasma-derived Medicinal Products Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Plasma-derived Medicinal Products Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Plasma-derived Medicinal Products Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Plasma-derived Medicinal Products Forecasted Market Size by Region
7.2.1 Asia-Pacific Plasma-derived Medicinal Products Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Plasma-derived Medicinal Products Sales in Value by Region (2024-2029)
8 Latin America Plasma-derived Medicinal Products by Country
8.1 Latin America Plasma-derived Medicinal Products Historic Market Size by Country
8.1.1 Latin America Plasma-derived Medicinal Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Plasma-derived Medicinal Products Sales in Volume by Country (2018-2023)
8.1.3 Latin America Plasma-derived Medicinal Products Sales in Value by Country (2018-2023)
8.2 Latin America Plasma-derived Medicinal Products Forecasted Market Size by Country
8.2.1 Latin America Plasma-derived Medicinal Products Sales in Volume by Country (2024-2029)
8.2.2 Latin America Plasma-derived Medicinal Products Sales in Value by Country (2024-2029)
9 Middle East and Africa Plasma-derived Medicinal Products by Country
9.1 Middle East and Africa Plasma-derived Medicinal Products Historic Market Size by Country
9.1.1 Middle East and Africa Plasma-derived Medicinal Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Plasma-derived Medicinal Products Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Plasma-derived Medicinal Products Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Plasma-derived Medicinal Products Forecasted Market Size by Country
9.2.1 Middle East and Africa Plasma-derived Medicinal Products Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Plasma-derived Medicinal Products Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Plasma-derived Medicinal Products Products Offered
10.1.5 Takeda Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CSL Plasma-derived Medicinal Products Products Offered
10.2.5 CSL Recent Development
10.3 Grifols
10.3.1 Grifols Company Information
10.3.2 Grifols Introduction and Business Overview
10.3.3 Grifols Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Grifols Plasma-derived Medicinal Products Products Offered
10.3.5 Grifols Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Introduction and Business Overview
10.4.3 Octapharma Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Octapharma Plasma-derived Medicinal Products Products Offered
10.4.5 Octapharma Recent Development
10.5 Kedrion
10.5.1 Kedrion Company Information
10.5.2 Kedrion Introduction and Business Overview
10.5.3 Kedrion Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Kedrion Plasma-derived Medicinal Products Products Offered
10.5.5 Kedrion Recent Development
10.6 LFB Group
10.6.1 LFB Group Company Information
10.6.2 LFB Group Introduction and Business Overview
10.6.3 LFB Group Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.6.4 LFB Group Plasma-derived Medicinal Products Products Offered
10.6.5 LFB Group Recent Development
10.7 Biotest
10.7.1 Biotest Company Information
10.7.2 Biotest Introduction and Business Overview
10.7.3 Biotest Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Biotest Plasma-derived Medicinal Products Products Offered
10.7.5 Biotest Recent Development
10.8 BPL
10.8.1 BPL Company Information
10.8.2 BPL Introduction and Business Overview
10.8.3 BPL Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.8.4 BPL Plasma-derived Medicinal Products Products Offered
10.8.5 BPL Recent Development
10.9 Shanghai RAAS
10.9.1 Shanghai RAAS Company Information
10.9.2 Shanghai RAAS Introduction and Business Overview
10.9.3 Shanghai RAAS Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Shanghai RAAS Plasma-derived Medicinal Products Products Offered
10.9.5 Shanghai RAAS Recent Development
10.10 China Biologic Products
10.10.1 China Biologic Products Company Information
10.10.2 China Biologic Products Introduction and Business Overview
10.10.3 China Biologic Products Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.10.4 China Biologic Products Plasma-derived Medicinal Products Products Offered
10.10.5 China Biologic Products Recent Development
10.11 Hualan Biological Engineering Inc.
10.11.1 Hualan Biological Engineering Inc. Company Information
10.11.2 Hualan Biological Engineering Inc. Introduction and Business Overview
10.11.3 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Products Offered
10.11.5 Hualan Biological Engineering Inc. Recent Development
10.12 Beijing Tiantan Biological Products Corp
10.12.1 Beijing Tiantan Biological Products Corp Company Information
10.12.2 Beijing Tiantan Biological Products Corp Introduction and Business Overview
10.12.3 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Products Offered
10.12.5 Beijing Tiantan Biological Products Corp Recent Development
10.13 Pacific Shuanglin
10.13.1 Pacific Shuanglin Company Information
10.13.2 Pacific Shuanglin Introduction and Business Overview
10.13.3 Pacific Shuanglin Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Pacific Shuanglin Plasma-derived Medicinal Products Products Offered
10.13.5 Pacific Shuanglin Recent Development
10.14 Boya Bio-Pharmaceutical
10.14.1 Boya Bio-Pharmaceutical Company Information
10.14.2 Boya Bio-Pharmaceutical Introduction and Business Overview
10.14.3 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Products Offered
10.14.5 Boya Bio-Pharmaceutical Recent Development
10.15 Paisi Feike Biology Pharmacy Co., Ltd.
10.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Information
10.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Introduction and Business Overview
10.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Products Offered
10.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
10.16 Xinjiang Deyuan Bioengineering
10.16.1 Xinjiang Deyuan Bioengineering Company Information
10.16.2 Xinjiang Deyuan Bioengineering Introduction and Business Overview
10.16.3 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Products Offered
10.16.5 Xinjiang Deyuan Bioengineering Recent Development
10.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
10.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
10.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Introduction and Business Overview
10.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Products Offered
10.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
10.18 Shenzhen Weiguang
10.18.1 Shenzhen Weiguang Company Information
10.18.2 Shenzhen Weiguang Introduction and Business Overview
10.18.3 Shenzhen Weiguang Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Shenzhen Weiguang Plasma-derived Medicinal Products Products Offered
10.18.5 Shenzhen Weiguang Recent Development
10.19 Shanxi Kangbao
10.19.1 Shanxi Kangbao Company Information
10.19.2 Shanxi Kangbao Introduction and Business Overview
10.19.3 Shanxi Kangbao Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Shanxi Kangbao Plasma-derived Medicinal Products Products Offered
10.19.5 Shanxi Kangbao Recent Development
10.20 Nanyue Biopharming Corporation Ltd
10.20.1 Nanyue Biopharming Corporation Ltd Company Information
10.20.2 Nanyue Biopharming Corporation Ltd Introduction and Business Overview
10.20.3 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Products Offered
10.20.5 Nanyue Biopharming Corporation Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Plasma-derived Medicinal Products Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Plasma-derived Medicinal Products Industrial Chain Analysis
11.4 Plasma-derived Medicinal Products Market Dynamics
11.4.1 Plasma-derived Medicinal Products Industry Trends
11.4.2 Plasma-derived Medicinal Products Market Drivers
11.4.3 Plasma-derived Medicinal Products Market Challenges
11.4.4 Plasma-derived Medicinal Products Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Plasma-derived Medicinal Products Distributors
12.3 Plasma-derived Medicinal Products Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
